for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Dynavax says FDA approves Heplisav-B for Hepatitis B prevention in adults

Nov 9 (Reuters) - Dynavax Technologies Corp

* Dynavax announces FDA approval of Heplisav-B for prevention of Hepatitis B in adults

* Dynavax Technologies Corp - expects to commercially launch Heplisav-B in United States in Q1 of 2018 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up